- In April 2024, Clearblue, a brand of SPD Swiss Precision Diagnostics GmbH, launched an upgraded version of its Connected Ovulation Test System with enhanced Bluetooth connectivity and AI-driven cycle prediction. This new version provides more personalized fertility insights and improved app integration, emphasizing the brand’s commitment to empowering women with accessible, technology-enhanced reproductive health tools that deliver greater accuracy and user control
- In March 2024, Mira, a leading provider of AI-based fertility monitoring devices, announced the release of its Mira Plus Analyzer, a multi-hormone digital fertility tracker capable of monitoring estrogen, LH, and progesterone levels. This development enables more comprehensive fertility profiling and supports both natural conception and fertility treatments, showcasing Mira’s continuous innovation in at-home hormone testing
- In February 2024, iProven introduced a new line of FDA-registered digital ovulation kits featuring smart display interfaces and app-based syncing. Designed to cater to tech-savvy and privacy-focused consumers, the product launch supports iProven’s strategic goal to expand its footprint in the U.S. and European consumer health markets with affordable, connected reproductive health solutions
- In January 2024, Easy@Home, a brand under Medimama Inc., announced a strategic expansion of its digital health portfolio with the integration of its ovulation test kits into its proprietary Premom app. The updated app allows real-time result logging and offers data-backed fertility recommendations. This development reflects the growing trend of combining diagnostic hardware with intelligent mobile platforms to improve health outcomes and engagement
- In December 2023, Femometer, a global digital health brand, launched the IVY Digital Ovulation Test Kit in Asian and European markets. With AI-powered LH surge detection and multilingual app support, this new offering strengthens Femometer’s position in emerging fertility tech markets by focusing on inclusivity, accessibility, and precise ovulation prediction for diverse populations worldwide
